75 related articles for article (PubMed ID: 10516731)
1. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.
Ayuk F; Li Z; Kühlcke K; Lindemann C; Schade U; Eckert HG; Zander A; Fehse B
Gene Ther; 1999 Oct; 6(10):1788-92. PubMed ID: 10516731
[TBL] [Abstract][Full Text] [Related]
2. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
[TBL] [Abstract][Full Text] [Related]
3. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.
Hagani AB; Rivière I; Tan C; Krause A; Sadelain M
J Gene Med; 1999; 1(5):341-51. PubMed ID: 10738551
[TBL] [Abstract][Full Text] [Related]
4. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract][Full Text] [Related]
5. Retroviral transduction of human peripheral blood lymphocytes with Bcl-X(L) promotes in vitro lymphocyte survival in pro-apoptotic conditions.
Eaton D; Gilham DE; O'Neill A; Hawkins RE
Gene Ther; 2002 Apr; 9(8):527-35. PubMed ID: 11948378
[TBL] [Abstract][Full Text] [Related]
6. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
7. Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy.
Stockschläder M; Haiss M; Exner S; Schmah O; Veelken H; Follo M; Rüger R; Finke J
J Hematother Stem Cell Res; 1999 Aug; 8(4):401-10. PubMed ID: 10634178
[TBL] [Abstract][Full Text] [Related]
8. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
[TBL] [Abstract][Full Text] [Related]
9. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression.
Zhou P; Lee J; Moore P; Brasky KM
Hum Gene Ther; 2001 Oct; 12(15):1843-55. PubMed ID: 11589827
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
[TBL] [Abstract][Full Text] [Related]
12. Retroviral gene transfer into primary human natural killer cells.
Alici E; Sutlu T; Sirac Dilber M
Methods Mol Biol; 2009; 506():127-37. PubMed ID: 19110624
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes.
Rudoll T; Phillips K; Lee SW; Hull S; Gaspar O; Sucgang N; Gilboa E; Smith C
Gene Ther; 1996 Aug; 3(8):695-705. PubMed ID: 8854095
[TBL] [Abstract][Full Text] [Related]
14. Optimization of retroviral vector generation for clinical application.
Schilz AJ; Kühlcke K; Fauser AA; Eckert HG
J Gene Med; 2001; 3(5):427-36. PubMed ID: 11601756
[TBL] [Abstract][Full Text] [Related]
15. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
[TBL] [Abstract][Full Text] [Related]
16. A novel 'sort-suicide' fusion gene vector for T cell manipulation.
Fehse B; Kustikova OS; Li Z; Wahlers A; Bohn W; Beyer WR; Chalmers D; Tiberghien P; Kühlcke K; Zander AR; Baum C
Gene Ther; 2002 Dec; 9(23):1633-8. PubMed ID: 12424616
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation.
Kühlcke K; Ayuk FA; Li Z; Lindemann C; Schilz A; Schade UM; Fauser AA; Zander AR; Eckert HG; Fehse B
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S96-8. PubMed ID: 10933199
[TBL] [Abstract][Full Text] [Related]
18. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
[TBL] [Abstract][Full Text] [Related]
19. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors.
Schroers R; Hildebrandt Y; Hasenkamp J; Glass B; Lieber A; Wulf G; Piesche M
Exp Hematol; 2004 Jun; 32(6):536-46. PubMed ID: 15183894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
